Search

Displaying results 4061 - 4070 of 10000 in total
  1. Target

    Glutathione peroxidase 6

    go.drugbank.com/bio_entities/BE0002286
    TargetHumans

    Polypeptides: Glutathione peroxidase 6Synonyms: GPx-6, GSHPx-6
  2. Target

    ActVA 6 protein

    go.drugbank.com/bio_entities/BE0002498
    TargetStreptomyces coelicolor

    Polypeptides: ActVA 6 protein
  3. Target

    Alcohol dehydrogenase 6

    go.drugbank.com/bio_entities/BE0003545
    EnzymeHumans

    Alcohol dehydrogenase (PubMed:1755855). Catalyzes the NAD-dependent oxidation of primary alcohols to the corresponding aldehydes (PubMed:1755855). Oxidizes secondary alcohols to the corresponding ketones (By similarity)

    Polypeptides: Alcohol dehydrogenase 6
  4. Target

    P2Y purinoceptor 6

    go.drugbank.com/bio_entities/BE0014552
    TargetHumans

    Receptor for extracellular UDP > UTP > ATP. The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system

    Polypeptides: P2Y purinoceptor 6
  5. Drug

    Levomenthol

    go.drugbank.com/drugs/DB00825
    ApprovedInvestigational

    Menthol is a covalent organic compound made synthetically or obtained from peppermint or other mint oils.

    Mixtures: KAMFOLIN 150 MG/G+100 MG/G MERHEM, 50 G, VİCKS İNHALER 415,4 MG + 415,4 MG/1 G BURUN ÇUBUĞUCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP3A Substrates
  6. Target

    4-hydroxythreonine-4-phosphate dehydrogenase

    go.drugbank.com/bio_entities/BE0001581
    TargetEscherichia coli (strain K12)

    Catalyzes the NAD(P)-dependent oxidation of 4-(phosphooxy)-L-threonine (HTP) into 2-amino-3-oxo-4-(phosphooxy)butyric acid which spontaneously decarboxylates to form 3-amino-2-oxopropyl phosphate (AHAP

    Polypeptides: 4-hydroxythreonine-4-phosphate dehydrogenaseSynonyms: 4-(phosphohydroxy)-L-threonine dehydrogenase
  7. Drug

    Ketoprofen

    go.drugbank.com/drugs/DB01009
    ApprovedInvestigationalVet approved

    Ketoprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with analgesic and antipyretic properties.

    Categories: Non COX-2 selective NSAIDS, Cytochrome P-450 SubstratesSynonyms: m-Benzoylhydratropic acid, 2-(3-Benzoylphenyl)propionic acid
  8. Drug

    Insulin glargine

    go.drugbank.com/drugs/DB00047
    ApprovedInvestigational

    Use of the higher concentrated Toujeo as compared to Lantus results in slightly different pharmacokinetics, with a later onset (up to 6 hours) and duration of action (up to 30 hours). … As of 2015, insulin glargine was reformulated by Sanofi as the product Toujeo in an extra-concentrated form containing 300IU/mL (compared to 100IU/mL contained in Lantus).

    Mixtures: Soliqua SoloStar 100units/mL+33mcg/mL solution for injection in a pre-filled pen, SOLIQUA SOLUTION FOR INJECTION IN A PRE-FILLED PEN 100UNITS/ML + 50MCG/MLCategories: Cytochrome P-450 CYP1A2 Inducers, Cytochrome P-450 Enzyme Inducers
  9. Drug

    Lormetazepam

    go.drugbank.com/drugs/DB13872
    Approved

    It is marketed by Auden Mckenzie (Pharma Division) in 0.5 and 1 mg tablet formulations. … Lormatazepam is an orally available benzodiazepine used in the UK for the treatment of short-term insomnia [L927].

    Categories: Heterocyclic Compounds, 2-RingSynonyms: 7-Chloro-1,3-dihydro-5-(o-chlorophenyl)-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one, 7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-hydroxy-1-methyl-2H-1,4-benzodiazepin-2-one
  10. Drug

    Gliclazide

    go.drugbank.com/drugs/DB01120
    ApprovedInvestigational

    a sulfonamide group able to release a proton and the presence of one aromatic group. … [A39546] On the other hand, based on the pharmacological efficacy, gliclazide is considered a second-generation sulfonylurea which presents a higher potency and a shorter half-life.

    Mixtures: DUODIA 80/500 MG TABLET, 60 ADET, GLIFOR PLUS 30 MG/1000 MG DEĞIŞTIRILMIŞ SALIMLI TABLET, 60 ADETCategories: Cytochrome P-450 Substrates, Cytochrome P-450 CYP2C9 Substrates